3D bioprinting of vascularized cardiac constructs reveals improved cardiomyocyte organization and contractile function
Journal of Pharmacy & Pharmaceutical Sciences · 02.11.2026 · 29
DOI: 10.3389/jpps.2026.17204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy & Pharmaceutical Sciences, online erschienen am 02.11.2026. Verfasst von Farinaz Ketabat und 7 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Despite advances in cardiac tissue engineering, generating constructs that simultaneously achieve vascularization and organized cardiomyocyte function remains a major challenge.
Methods
In this study, three-dimensional (3D) bioprinting was used to fabricate human umbilical vein endothelial cell (HUVEC)-laden alginate/gelatin constructs with defined architectures designed to mimic myocardial alignment. Constructs were cultured with vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) under static conditions followed by short-term dynamic stimulation in a bioreactor. Cardiomyocytes - H9c2 cells, neonatal rat ventricular myocytes (NRVMs), or human induced pluripotent stem cell–derived cardiomyocytes (iPSC-CMs) - were subsequently seeded onto the constructs. Vascularization and the distribution of cells were assessed using immunofluorescence, and functional activity of cardiomyocytes was evaluated by calcium transient imaging.
Results
Bioprinted constructs developed interconnected CD31-positive endothelial networks in response to growth factor supplementation and dynamic culture, whereas control constructs cultured without growth factors or bioreactor exposure showed limited vascular organization. Cardiomyocytes seeded onto vascularized constructs exhibited improved structural organization, including increased alignment and integration with endothelial networks. Functional assessment revealed more synchronized and rhythmic calcium transients compared to non-vascularized constructs.
Conclusion
This study demonstrates that combining 3D bioprinting with controlled architectural design and endothelial network formation enhances cardiomyocyte organization and function. These findings highlight the critical role of vascular-like networks in improving the performance of engineered cardiac tissues.
Zitieren
APA
Ketabat, F., Kim, A., Sardroud, H. A., Eames, B. F., Collins, M., Chen, X., Kelly, M. E., & Badea, I. (2026). 3D bioprinting of vascularized cardiac constructs reveals improved cardiomyocyte organization and contractile function. Journal of Pharmacy & Pharmaceutical Sciences, 29. https://doi.org/10.3389/jpps.2026.17204
Vancouver
Ketabat F, Kim A, Sardroud HA, Eames BF, Collins M, Chen X, et al. 3D bioprinting of vascularized cardiac constructs reveals improved cardiomyocyte organization and contractile function. Journal of Pharmacy & Pharmaceutical Sciences. 2026;29. doi:10.3389/jpps.2026.17204
BibTeX
@article{Ketabat2026,
author = {Ketabat, Farinaz and Kim, Andy and Sardroud, Hamed Alizadeh and Eames, Brian Frank and Collins, Michelle and Chen, Xiongbiao and Kelly, Michael E. and Badea, Ildiko},
title = {3D bioprinting of vascularized cardiac constructs reveals improved cardiomyocyte organization and contractile function},
journal = {Journal of Pharmacy & Pharmaceutical Sciences},
year = {2026},
volume = {29},
doi = {10.3389/jpps.2026.17204}
}
EUVIMED